{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:05:04Z","timestamp":1770822304701,"version":"3.50.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1053\/j.seminhematol.2005.08.001","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"196-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Chromosomal Abnormalities and Molecular Markers in Myeloproliferative Disorders"],"prefix":"10.1053","volume":"42","author":[{"given":"Anthony J.","family":"Bench","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike L.","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2005.08.001_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","article-title":"Agnogenic myeloid metaplasia","volume":"51","author":"Jacobson","year":"1978","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib4","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2002-07-2287","article-title":"Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin","volume":"101","author":"Liu","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/clinchem\/44.1.61","article-title":"X-chromosome inactivation in healthy females","volume":"44","author":"El Kassar","year":"1998","journal-title":"Clin Chem"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1046\/j.1365-2141.1998.00867.x","article-title":"Unbalanced X-chromosome inactivation in haemopoietic cells from normal women","volume":"102","author":"Tonon","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.183.2.561","article-title":"Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism","volume":"183","author":"Prchal","year":"1996","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib9","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood.V83.10.2899.2899","article-title":"Tissue specificity of X-chromosome inactivation patterns","volume":"83","author":"Gale","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib10","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood.V88.7.2690.bloodjournal8872690","article-title":"Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera","volume":"88","author":"Asimakopoulos","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ajcp\/112.1.93","article-title":"Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis","volume":"112","author":"Mitterbauer","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V89.1.128","article-title":"Clonality analysis of hematopoiesis in essential thrombocythemia","volume":"89","author":"El-Kassar","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1365-2141.1997.1933010.x","article-title":"Clonal haemopoiesis in normal elderly women","volume":"97","author":"Champion","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.1997.2573078.x","article-title":"Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age","volume":"98","author":"Gale","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib15","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood.V95.7.2449","article-title":"X-linked genetic factors regulate hematopoietic stem-cell kinetics in females","volume":"95","author":"Christensen","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/bcmd.1998.0213","article-title":"X chromosome inactivation patterns in normal females","volume":"24","author":"Racchi","year":"1998","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood.V100.5.1596.h81702001596_1596_1601","article-title":"Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia","volume":"100","author":"Shih","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/beha.2001.0153","article-title":"Myeloproliferative disorders","volume":"14","author":"Bench","year":"2001","journal-title":"Baillieres Best Pract Clin Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V72.2.386.386","article-title":"A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course","volume":"72","author":"Swolin","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0025-6196(12)61011-8","article-title":"Chromosome studies in 104 patients with polycythemia vera","volume":"68","author":"Diez Martin","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2141.2001.02796.x","article-title":"Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia","volume":"113","author":"Tefferi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib23","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1182\/blood-2004-11-4319","article-title":"Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia","volume":"105","author":"Strasser-Weippl","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2141.2000.02242.x","article-title":"The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera","volume":"110","author":"Westwood","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib25","first-page":"1","article-title":"Exploring polycythemia vera with FISH","volume":"119","author":"Najfeld","year":"2002","journal-title":"Br J Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0165-4608(93)90075-W","article-title":"Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms","volume":"68","author":"Dewald","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib27","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/sj.onc.1203728","article-title":"Chromosome 20 deletions in myeloid malignancies","volume":"19","author":"Bench","year":"2000","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib28","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood.V83.10.2809.2809","article-title":"Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells","volume":"83","author":"White","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib29","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2002-07-2341","article-title":"Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia","volume":"101","author":"Reeder","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1098-2264(199802)21:2<75::AID-GCC1>3.0.CO;2-4","article-title":"Refinement of the commonly deleted segment in myeloid leukemias with a del(20q)","volume":"21","author":"Wang","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib31","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/sj.onc.1202732","article-title":"A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomes","volume":"18","author":"Koga","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib32","doi-asserted-by":"crossref","first-page":"15412","DOI":"10.1074\/jbc.M300592200","article-title":"The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6)","volume":"278","author":"Boccuni","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.2004.05278.x","article-title":"Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies","volume":"127","author":"Bench","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/gcc.20087","article-title":"Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells","volume":"41","author":"MacGrogan","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib35","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1073\/pnas.0308195101","article-title":"Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies","volume":"101","author":"Li","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V91.1.231","article-title":"Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies","volume":"91","author":"La Starza","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib37","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib38","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1182\/blood.V99.11.4116","article-title":"Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia","volume":"99","author":"Mertens","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib39","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera","volume":"30","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2003-03-0744","article-title":"Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders","volume":"102","author":"Kralovics","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib42","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2003-03-0885","article-title":"Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease","volume":"102","author":"Kralovics","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib43","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gcc.10297","article-title":"Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia","volume":"39","author":"Andrieux","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.leu.2403605","article-title":"Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies","volume":"19","author":"Odero","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V96.2.699","article-title":"ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain","volume":"96","author":"Xiao","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/gcc.20023","article-title":"Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome","volume":"40","author":"Grand","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib48","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib49","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2003-06-1824","article-title":"The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia","volume":"103","author":"Gotlib","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib50","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2004-01-0246","article-title":"Imatinib targets other than bcr\/abl and their clinical relevance in myeloid disorders","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib51","first-page":"64","article-title":"In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders","volume":"34","author":"Weinberg","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0037-1963(01)90135-0","article-title":"Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders","volume":"38","author":"Prchal","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib53","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197406132902419","article-title":"Bone-marrow responses in polycythemia vera","volume":"290","author":"Prchal","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10428199609074366","article-title":"Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias","volume":"22","author":"Westwood","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib55","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI109003","article-title":"Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin","volume":"61","author":"Prchal","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib56","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0950-3536(98)80040-1","article-title":"Haematopoietic progenitors and signal transduction in polycythaemia vera and primary thrombocythaemia","volume":"11","author":"Kralovics","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/sj.thj.6200123","article-title":"Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia","volume":"2","author":"Dobo","year":"2001","journal-title":"Hematol J"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib58","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V83.3.744.744","article-title":"Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay","volume":"83","author":"Shih","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib59","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00277-004-0864-9","article-title":"PRV-1 mRNA expression discriminates two types of essential thrombocythemia","volume":"83","author":"Griesshammer","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000064709","article-title":"Polycythaemia vera","volume":"108","author":"Pahl","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib62","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI115009","article-title":"Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3","volume":"87","author":"Dai","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.1994.tb03246.x","article-title":"Polycythemia vera III","volume":"86","author":"Dai","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib64","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","article-title":"Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia","volume":"90","author":"Horikawa","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib65","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib66","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V94.8.2555.420k14_2555_2561","article-title":"Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera","volume":"94","author":"Moliterno","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib67","first-page":"469a","article-title":"Enhanced in vitro viability of polycythemia vera CD34+ cells is associated with abnormal thrombopoietin receptor expression and aberrant signal transduction","volume":"98","author":"Moliterno","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2141.2000.01794.x","article-title":"Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera","volume":"108","author":"Le Blanc","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib69","first-page":"512a","article-title":"A diagnostic assay for polycythemia vera","volume":"96","author":"Moliterno","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2000.02430.x","article-title":"The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia","volume":"111","author":"Li","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2141.1999.01667.x","article-title":"Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value","volume":"107","author":"Harrison","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib72","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V96.2.771","article-title":"Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V100.2.714","article-title":"The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia","volume":"100","author":"Teofili","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib74","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V95.8.2569","article-title":"Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera","volume":"95","author":"Temerinac","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib75","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2003-03-0919","article-title":"Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis","volume":"102","author":"Klippel","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib76","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1182\/blood-2003-10-3488","article-title":"Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients","volume":"103","author":"Cilloni","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib77","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2003-10-3502","article-title":"Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia","volume":"103","author":"Florensa","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib78","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.patbio.2003.09.019","article-title":"Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders","volume":"52","author":"Klippel","year":"2004","journal-title":"Pathol Biol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib79","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.2002.11.507","article-title":"Overexpression of polycythemia rubra vera-1 gene in essential thrombocythemia","volume":"20","author":"Teofili","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib80","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1182\/blood-2004-06-2160","article-title":"The PRV-1 gene expression in essential thrombocythemia","volume":"104","author":"Teofili","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib81","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2003-10-3505","article-title":"Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia","volume":"103","author":"Tefferi","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib82","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2141.2004.05098.x","article-title":"Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders","volume":"126","author":"Passamonti","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib83","first-page":"406","article-title":"Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlates","volume":"90","author":"Sirhan","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib84","first-page":"749","article-title":"Instability of PRV-1 mRNA","volume":"89","author":"Jelinek","year":"2004","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib85","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1373\/clinchem.2003.028530","article-title":"Method Comparison of PRV-1 mRNA quantification in whole blood leukocytes and purified granulocytes","volume":"50","author":"Palmqvist","year":"2004","journal-title":"Clin Chem"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib86","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2141.2003.04634.x","article-title":"Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia","volume":"123","author":"Johansson","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib87","first-page":"851","article-title":"Thrombotic complications in four subpopulations of patients with ET defined by c-Mpl protein expression and PRV-1 mRNA levels","volume":"90","author":"Goerttler","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib88","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2141.2004.05175.x","article-title":"PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia","volume":"127","author":"Vannucchi","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib89","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1182\/blood-2002-03-0949","article-title":"Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera","volume":"100","author":"Klippel","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib90","first-page":"2307a","article-title":"PRV-1\/NB1\/CD177 physically interacts with the growth regulatory proteoglycan decorin","volume":"100","author":"Coch","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib91","first-page":"405","article-title":"Expression of polycythemia rubra vera-1 decreases the dependency of cells on growth factors for proliferation","volume":"90","author":"Mnjoyan","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib92","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(01)00194-7","article-title":"Signatures of the immune response","volume":"15","author":"Shaffer","year":"2001","journal-title":"Immunity"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib94","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib95","first-page":"3940","article-title":"Gene expression profiling in polycythemia vera using cDNA microarray technology","volume":"63","author":"Pellagatti","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib96","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05416.x","article-title":"Gene expression profiling in polycythaemia vera","volume":"129","author":"Goerttler","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib97","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2003-07-2597","article-title":"Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells","volume":"104","author":"Tenedini","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib98","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/362722a0","article-title":"Erythroid transcription factor NF-E2 is a hematopoietic-specific basic-leucine zipper protein","volume":"362","author":"Andrews","year":"1993","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib99","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1006\/bbrc.1996.0307","article-title":"Abundant expression of erythroid transcription factor P45 NF-E2 mRNA in human peripheral granurocytes","volume":"219","author":"Toki","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib100","doi-asserted-by":"crossref","first-page":"25292","DOI":"10.1074\/jbc.M908695199","article-title":"Ectopic expression of transcription factor NF-E2 alters the phenotype of erythroid and monoblastoid cells","volume":"275","author":"Sayer","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib101","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0609.1987.tb00012.x","article-title":"Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia","volume":"38","author":"Eridani","year":"1987","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib102","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1172\/JCI117927","article-title":"Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis","volume":"95","author":"Labbaye","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib103","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib104","first-page":"27","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"27","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib106","first-page":"797a","article-title":"Quantification of c-Mpl Protein Expression and PRV-1 mRNA levels distinguish four distinct subpopulations of patients with ET","volume":"100","author":"Goerttler","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib107","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-04-1515","article-title":"The Jak2V617F mutation, PRV-1 overexpression and EEC formation define a similar cohort of MPD patients","author":"Goerttler","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib108","first-page":"26","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"26","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.001_bib109","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/1024533031000107488","article-title":"Molecular markers in myeloproliferative disorders","volume":"8","author":"Pahl","year":"2003","journal-title":"Hematology"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196305001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196305001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:16:24Z","timestamp":1758521784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196305001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0037196305001435"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.08.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromosomal Abnormalities and Molecular Markers in Myeloproliferative Disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}